Further, through a series of in vivo function assays, we demonstrated that FOXQ1 knockdown inhibited the CRC xenograft formation through repressing CRC-related intestinal bacteria via modulation of the SIRT1/β-catenin axis in radiation-resistant CRC cells. The gene discussed is FOXQ1; the disease is colorectal carcinoma.